Point-Of-Care Molecular Diagnostics Market Detailed Analysis, Upcoming Trends, Growth Outlook, Demand And Global Industry Opportunities || Abbott Laboratories, F. Hoffmann-La Roche Ltd, BioMérieux SA

The global point-of-care molecular diagnostics market size is expected to grow from $2.50 billion in 2021 to $2.78 billion in 2022 at a compound annual growth rate (CAGR) of 11.18%. The global point-of-care molecular diagnostics market size is expected to reach $4.32 billion in 2026 at a compound annual growth rate (CAGR) of 11.59%.

The Business Research Company offers the Point-Of-Care (POC) Molecular Diagnostics Global Market Report 2022 in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market's historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.

Request Free Sample Copy of This Research Study:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7046&type=smp

The point-of-care (POC) molecular diagnostics market consists of sales of point-of-care (POC) molecular diagnostics products and equipment by entities (organizations, sole traders, and partnerships) that are used for the detection of disease antigens or antibodies in human samples, such as mononucleosis, influenza, and group A streptococcus (GAS). It refers to tests that detect the presence of specific nucleic acids in a clinical specimen, such as feces, saliva, urine, blood, and tissue. This molecular diagnostic is based on seeing targeted portions of microbial genetic material, DNA or RNA. It is utilized by the healthcare sector to detect emergency usage authorization to diagnose diseases.

Some key point-of-care (POC) molecular diagnostics market players are Abbott Laboratories, F. Hoffmann-La Roche Ltd, BioMérieux SA, Danaher Corporation, Quidel Corporation, Qiagen Gmbh, Biocartis NV, Nova Biomedical, Thermo Fisher Scientific, Dickinson and Company.

The countries covered in the global point-of-care (POC) molecular diagnostics market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam.

The regions covered in the global point-of-care (POC) molecular diagnostics market are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Point-Of-Care (Poc) Molecular Diagnostics Market Segmentation:
By Product and Service
1. Assays and Kits
2. Instruments and Analyzers
3. Software and Services

By Technology
1. Reverse Transcription - Polymerase Chain Reaction (RT-PCR)
2. In Situ Hybridization
3. Sequencing

By Application
1. Respiratory Diseases
2. Hospital Acquired Infections (HAIs)
3. Cancer/Oncology
4. Hepatitis
5. Hematology

By End-User
1. Decentralized Labs
2. Hospitals
3. Home Care
4. Assisted Living Healthcare Facilities

See More On The Report At -
https://www.thebusinessresearchcompany.com/report/point-of-care-molecular-diagnostics-global-market-report

The Report's Table Of Contents includes
1. Executive Summary
2. Point-Of-Care (POC) Molecular Diagnostics Market Characteristics
3. Point-Of-Care (POC) Molecular Diagnostics Market Trends and Strategies
4. Impact of Covid-19 on Point-Of-Care (POC) Molecular Diagnostics
5. Point-Of-Care (POC) Molecular Diagnostics Market Size and Growth
………
28. Key Mergers and Acquisitions in The Point-Of-Care (POC) Molecular Diagnostics Market
29. Point-Of-Care (POC) Molecular Diagnostics Market Future Outlook and Potential Analysis
30. Appendix

This report covers the trends and market dynamics of the point-of-care (POC) molecular diagnostics market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Directly Purchase the Report Here: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7046

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Check out our blog: http://blog.tbrc.info/

And follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

About Us:
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that excels in company, market, and consumer research. It has published over 3000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

This release was published on openPR.